+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Activity of piperacillin/tazobactam in combination with amikacin , trovafloxacin , and ciprofloxacin against Pseudomonas aeruginosa



Activity of piperacillin/tazobactam in combination with amikacin , trovafloxacin , and ciprofloxacin against Pseudomonas aeruginosa



Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 39: 289




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034350684

Download citation: RISBibTeXText


Related references

Activity of piperacillin/tazobactam in combination with amikacin, ciprofloxacin, and trovafloxacin against Pseudomonas aeruginosa by time-kill. Diagnostic Microbiology & Infectious Disease 38(1): 37-41, 2000

Activity of levofloxacin and ciprofloxacin in combination with cefepime, ceftazidime, imipenem, piperacillin-tazobactam and amikacin against different Pseudomonas aeruginosa phenotypes and Acinetobacter spp. ChemoTherapy 50(4): 202-210, 2004

In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa. Antimicrobial Agents and ChemoTherapy 39(8): 1711-1716, 1995

In vitro Activity of Combination Therapy with Cefepime, Piperacillin-Tazobactam, or Meropenem with Ciprofloxacin against Multidrug-Resistant Pseudomonas aeruginosa Strains. Chemotherapy 49(6): 294-297, 2003

In vitro activity of combination therapy with cefepime, piperacillin-tazobactam, or meropenem with ciprofloxacin against multidrug-resistant Pseudomonas aeruginosa strains. ChemoTherapy 49(6): 294-297, 2003

Cefepime, piperacillin/tazobactam, gentamicin, ciprofloxacin, and levofloxacin alone and in combination against Pseudomonas aeruginosa. Diagnostic Microbiology & Infectious Disease 44(1): 35-41, 2002

Time-kill study of the activity of trovafloxacin compared with ciprofloxacin, sparfloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against six anaerobes. Journal of Antimicrobial ChemoTherapy 39 Suppl B: 23-27, 1997

Synergistic activity of gentamicin, ciprofloxacin, and levofloxacin in combination with cefepime and piperacillin/tazobactam against P aeruginosa. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 170-171, 2001

Comparative antibacterial activities of meropenem , imipenem , ceftazidime , piperacillin/tazobactam , ciprofloxacin and tobramycin , singly and in combination against resistant and susceptible isolates of Pseudomonas aeruginosa. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 35: 104, 1995

Comparison of the Bactericidal Activity of Trovafloxacin and Ciprofloxacin, Alone and in Combination with Cefepime, against Pseudomonas aeruginosa. Chemotherapy 46(6): 383-389, 2000

Comparison of the bactericidal activity of trovafloxacin and ciprofloxacin, alone and in combination with cefepime, against Pseudomonas aeruginosa. ChemoTherapy 46(6): 383-389, 2000

Serum bactericidal activity of piperacillin/tazobactam against Staphylococcus aureus, piperacillin-susceptible and piperacillin-resistant Escherichia coli and Pseudomonas aeruginosa. ChemoTherapy 50(1): 27-30, 2004

In vitro activity of tazobactam and piperacillin combination against 224 strains of Pseudomonas aeruginosa according to the production of beta-lactamase. Pathologie-Biologie 39(5): 361-366, 1991

Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem. Antimicrobial Agents and ChemoTherapy 40(3): 772-775, 1996

Synergistic effect of polyethylenimine plus piperacillin/tazobactam on clinical Pseudomonas aeruginosa isolates resistant to piperacillin/tazobactam. Annals of Microbiology 56(4): 345-348, 2006